KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Tax Provisions (2016 - 2025)

Gilead Sciences' Tax Provisions history spans 17 years, with the latest figure at -$450.0 million for Q4 2025.

  • For Q4 2025, Tax Provisions fell 216.88% year-over-year to -$450.0 million; the TTM value through Dec 2025 reached $941.0 million, up 345.97%, while the annual FY2025 figure was $1.3 billion, 509.48% up from the prior year.
  • Tax Provisions reached -$450.0 million in Q4 2025 per GILD's latest filing, down from $589.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $852.0 million in Q3 2021 to a low of -$450.0 million in Q4 2025.
  • Average Tax Provisions over 5 years is $286.2 million, with a median of $375.5 million recorded in 2021.
  • Peak YoY movement for Tax Provisions: crashed 303.42% in 2024, then skyrocketed 298.32% in 2025.
  • A 5-year view of Tax Provisions shows it stood at $383.0 million in 2021, then rose by 3.92% to $398.0 million in 2022, then plummeted by 40.45% to $237.0 million in 2023, then surged by 62.45% to $385.0 million in 2024, then plummeted by 216.88% to -$450.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Tax Provisions are -$450.0 million (Q4 2025), $589.0 million (Q3 2025), and $468.0 million (Q2 2025).